44 results on '"Kollmar, Rainer"'
Search Results
2. Neurointensivmedizin verbindet Neuro-Fächer: Schwerste nichtvaskuläre Hirnfunktionsstörungen und Syndrome.
- Author
-
Bösel, Julian and Kollmar, Rainer
- Published
- 2023
- Full Text
- View/download PDF
3. Erratum zu: Das ist neu in der Neurointensiv- und Notfallmedizin: die wichtigsten Studien des Jahres im Rück- und Überblick.
- Author
-
Alonso, Angelika, Kollmar, Rainer, and Dimitriadis, Konstantin
- Published
- 2022
- Full Text
- View/download PDF
4. Is Hypothermia Helpful in Severe Subarachnoid Hemorrhage? An Exploratory Study on Macro Vascular Spasm, Delayed Cerebral Infarction and Functional Outcome after Prolonged Hypothermia.
- Author
-
Kuramatsu, Joji B., Kollmar, Rainer, Gerner, Stefan T., Madžar, Dominik, Pisarčíková, andrea, Staykov, Dimitre, Kloska, Stephan P., Doerfler, arnd, Eyüpoglu, Ilker Y., Schwab, Stefan, and Huttner, Hagen B.
- Subjects
- *
THERAPEUTIC hypothermia , *SUBARACHNOID hemorrhage , *CEREBRAL infarction , *BLOOD circulation disorders , *CEREBROVASCULAR disease patients - Abstract
Background: Therapeutic hypothermia (TH) is an established treatment after cardiac arrest and growing evidence supports its use as neuroprotective treatment in stroke. Only few and heterogeneous studies exist on the effect of hypothermia in subarachnoid hemorrhage (SAH). A novel approach of early and prolonged TH and its influence on key complications in poor-grade SAH, vasospasm and delayed cerebral ischemia (DCI) was evaluated. Methods: This observational matched controlled study included 36 poor-grade (Hunt and Hess Scale >3 and World Federation of Neurosurgical Societies Scale >3) SAH patients. Twelve patients received early TH (<48 h after ictus), mild (35°C), prolonged (7 ± 1 days) and were matched to 24 patients from the prospective SAH database. Vasospasm was diagnosed by angiography, macrovascular spasm serially evaluated by Doppler sonography and DCI was defined as new infarction on follow-up CT. Functional outcome was assessed at 6 months by modified Rankin Scale (mRS) and categorized as favorable (mRS score 0-2) versus unfavorable (mRS score 3-6) outcome. Results: Angiographic vasospasm was present in 71.0% of patients. TH neither influenced occurrence nor duration, but the degree of macrovascular spasm as well as peak spastic velocities were significantly reduced (p < 0.05). Frequency of DCI was 87.5% in non-TH vs. 50% in TH-treated patients, translating into a relative risk reduction of 43% and preventive risk ratio of 0.33 (95% CI 0.14-0.77, p = 0.036). Favorable functional outcome was twice as frequent in TH-treated patients 66.7 vs. 33.3% of non-TH (p = 0.06). Conclusion: Early and prolonged TH was associated with a reduced degree of macrovascular spasm and significantly decreased occurrence of DCI, possibly ameliorating functional outcome. TH may represent a promising neuroprotective therapy possibly targeting multiple pathways of DCI development, notably macrovascular spasm, which strongly warrants further evaluation of its clinical impact. © 2015 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
5. DEcompressive surgery Plus hypo THermia for Space- Occupying Stroke ( DEPTH-SOS): a protocol of a multicenter randomized controlled clinical trial and a literature review.
- Author
-
Neugebauer, Hermann, Kollmar, Rainer, Niesen, Wolf-Dirk, Bösel, Julian, Schneider, Hauke, Hobohm, Carsten, Zweckberger, Klaus, Heuschmann, Peter U., Schellinger, Peter D., and Jüttler, Eric
- Subjects
- *
STROKE treatment , *DECOMPRESSIVE craniectomy , *CEREBRAL infarction , *HYPOTHERMIA , *MORTALITY , *RANDOMIZED controlled trials , *SYSTEMATIC reviews - Abstract
Rationale Although decompressive hemicraniectomy clearly reduces mortality in severe space-occupying middle cerebral artery infarction (so-called malignant middle cerebral artery infarction), every fifth patient still dies in the acute phase and every third patient is left with moderate to severe disability. Therapeutic hypothermia is a neuroprotective and antiedematous treatment option that has shown promising effects in severe stroke. A combination of both treatment strategies may have the potential to further reduce mortality and morbidity in malignant middle cerebral artery infarction, but needs evaluation of its efficacy within the setting of a randomized clinical trial. Aims The DEcompressive surgery Plus hypo THermia for Space- Occupying Stroke ( DEPTH-SOS) trial aims to investigate safety and feasibility of moderate therapeutic hypothermia (33° C ± 1) over at least 72 h in addition to early decompressive hemicraniectomy (≤48 hours after symptom onset) in patients with malignant middle cerebral artery infarction. Design The DEcompressive surgery Plus hypo THermia for Space- Occupying Stroke is a prospective, multicenter, open, two-arm (1:1) comparative, randomized, controlled trial. Study outcomes The primary end-point is mortality at day 14. The secondary end-points include functional outcome at day 14 and at 12 months follow-up, and complications related to hypothermia. Discussion The results of this trial will provide data on safety and feasibility of moderate hypothermia in addition to decompressive hemicraniectomy in malignant middle cerebral artery infarction. Furthermore, efficacy data on early mortality and long-term functional outcome will be obtained, forming the basis of subsequent trials. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
6. Cooling in intracerebral hemorrhage ( CINCH) trial: protocol of a randomized German- Austrian clinical trial.
- Author
-
Kollmar, Rainer, Juettler, Eric, Huttner, Hagen B., Dörfler, Arnd, Staykov, Dimitre, Kallmuenzer, Bernd, Schmutzhard, Erich, Schwab, Stefan, and Broessner, Gregor
- Subjects
- *
CEREBRAL hemorrhage , *CLINICAL trials , *STROKE , *MORTALITY , *THERAPEUTICS - Abstract
Background Intracerebral hemorrhage accounts for up to 15% of all strokes and is frequently associated with poor functional outcome and high mortality. So far, there is no clear evidence for a specific therapy, apart from general stroke unit or neurointensive care and management of secondary complications. Promising experimental and pilot clinical data support the use of therapeutic hypothermia after intracerebral hemorrhage. Aims The study aims to determine if therapeutic hypothermia improves survival rates and reduces cerebral lesion volume after large intracerebral hemorrhage compared with conventional treatment. Material and methods The Cooling in IntraCerebral Hemorrhage trial is a prospective, multicenter, interventional, randomized, parallel, two-arm (1 : 1) phase II trial with blinded end-point adjudication. Enrolment: 50 patients (age: 18 to 65 years) with large (25 to 64 ml on cranial computertomography), primary intracerebral hemorrhage of the basal ganglia or thalamus within 6 to 18 h after symptom onset are randomly allocated to therapeutic hypothermia for eight-days or conventional temperature management. In the therapeutic hypothermia group, a target temperature of 35·0° C is achieved by endovascular catheters and followed by slow controlled rewarming. Data analysis is based on the intent-to-treat population. The primary outcome measure of the study is the development in total lesion volume on cranial computertomography (intracerebral hemorrhage plus perihemorrhagic edema on day 8 ± 0·5 and day 11 ± 0·5 after intracerebral hemorrhage) and the mortality after 30 days. Secondary end-points are the in-hospital mortality, mortality, and functional outcome (modified Rankin Scale and Barthel-Index) after 90 and 180 days. Safety measures include any adverse events associated with therapeutic hypothermia. Discussion In the face of a lack of evidence-based therapies for patients with large intracerebral hemorrhage, new promising approaches are desperately needed, but need evaluation in randomized controlled trials. Conclusion The results of Cooling in IntraCerebral Hemorrhage trial are believed to directly influence future therapy of large intracerebral hemorrhage. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
7. Temperature Management in Stroke - an Unsolved, but Important Topic.
- Author
-
Kallmünzer, Bernd and Kollmar, Rainer
- Subjects
- *
BODY temperature , *CEREBROVASCULAR disease patients , *HYPOTHERMIA treatment , *ANTIPYRETICS , *NEUROPROTECTIVE agents , *NEUROSCIENCES - Abstract
Clinical data clearly show that elevated body temperature contributes to an unfavorable outcome after ischemic and hemorrhagic stroke. Two promising therapeutic strategies arise from this observation: (1) treatment of fever aiming to sustain normothermia and (2) induced hypothermia, targeting core body temperatures below 36.5°C. A limited number of studies investigated antipyretic strategies after acute stroke and their results were rather disappointing in terms of clinical efficacy. For that reason, it remains unproven, whether sufficient fever treatment improves functional outcome. On the other hand, strong experimental evidence supports neuroprotective effects of induced hypothermia after stroke. Yet, clinical data on this topic remain preliminary and rely on a limited number of patients, mostly enrolled in nonrandomized trials. Therefore, induced hypothermia may be considered safe and feasible after ischemic stroke, but little can be said regarding efficacy. This review summarizes the data, both on fever treatment and induced hypothermia following stroke, starting with a synopsis of the most important experimental investigations, leading to the latest clinical trials. Given the promising data and the lack of successful acute neuroprotective therapies available thus far, suggestions are given for future investigation on both topics. Copyright © 2011 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
8. G-CSF, rt-PA and combination therapy after experimental thromboembolic stroke.
- Author
-
Kollmar, Rainer, Henninger, Nils, Urbanek, Christian, and Schwab, Stefan
- Subjects
- *
THROMBOEMBOLISM , *GRANULOCYTE-colony stimulating factor , *CLINICAL trials , *NEUROPROTECTIVE agents , *MAGNETIC resonance imaging - Abstract
Background: Granulocyte Colony-Stimulating Factor (G-CSF) has remarkable neuroprotective properties. Due to its proven safety profile, G-CSF is currently used in clinical stroke trials. As neuroprotectants are considered to be more effective in the early phase of cerebral ischemia and during reperfusion, G-CSF should to be tested in combination with thrombolysis. Therefore, combination therapy was investigated in an experimental model of thromboembolic stroke. Methods: Male Wistar rats (n = 72) were subjected to a model of thromboembolic occlusion (TE) of the middle cerebral artery. Different groups (n = 12 each) treated by recombinant tissue-plasminogen activator (rt-PA) or/and GCSF: group control (control), group early G-CSF (G-CSF 60 min after TE), group rt-PA (rt-PA 60 min after TE), group com (combination rt-PA/G-CSF), group delayed rt-PA (rt-PA after 180 min), group deco (G-CSF after 60 min, rt-PA after 180 min). Animals were investigated by magnetic resonance imaging (MRI) and silver infarct staining (SIS) 24 hours after TE. Results: Early G-CSF or rt-PA reduced the infarct size compared to all groups (p < 0.05 to p < 0.01) with the exception of group com, (p = n.s.) as measured by T2, DWI, and SIS. Late administration of rt-PA lead to high mortality and larger infarcts compared to all other groups (p < 0.05 to p < 0.01). Pre-treatment by G-CSF (deco) reduced infarct site compared to delayed rt-PA treatment (p < 0.05). G-CSF did not significantly influence PWI when combined with rt-PA. All animals treated by rt-PA showed improved parameters in PWI indicating reperfusion. Conclusions: G-CSF was neuroprotective when given early after TE. Early combination with rt-PA showed no additional benefit compared to rt-PA or G-CSF alone, but did not lead to side effects. Pretreatment by G-CSF was able to reduce deleterious effects of late rt-PA treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
9. Critical illness polyneuropathy and myopathy in the intensive care unit.
- Author
-
Zink, Wolfgang, Kollmar, Rainer, and Schwab, Stefan
- Subjects
- *
NEUROPATHY , *MUSCLE diseases , *INTENSIVE care units , *MECHANICAL ventilators ,NEUROMUSCULAR disease diagnosis - Abstract
Critical illness polyneuropathy (CIP) and critical illness myopathy (CIM) are major complications that occur in severely ill patients who require intensive care treatment. CIP and CIM affect the limb and respiratory muscles, and, as a consequence, they characteristically complicate weaning from the ventilator, increase the length of stay on the intensive care unit, and prolong physical rehabilitation. The basic pathophysiology of both disorders is complex and involves metabolic, inflammatory and bioenergetic alterations. It is unclear at present whether CIP and CIM are distinct entities, or whether they just represent different 'organ' manifestations of a common pathophysiological mechanism. This article provides an overview of the clinical and diagnostic features of CIP and CIM and discusses current pathophysiological and therapeutic concepts relating to these neuromuscular disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
10. Combination therapy of moderate hypothermia and thrombolysis in experimental thromboembolic stroke—An MRI study
- Author
-
Kollmar, Rainer, Henninger, Nils, Bardutzky, Jürgen, Schellinger, Peter D., Schäbitz, Wolf-Rüdiger, and Schwab, Stefan
- Subjects
- *
HYPOTHERMIA , *MEDICAL imaging systems , *PRECIOUS metals , *SILVER - Abstract
Thrombolysis (T) is limited by reperfusion-associated injury and the short therapeutic window after stroke onset. The present study investigates whether hypothermia alone or in combination with thrombolysis has beneficial effects after experimental thromboembolic stroke. Wistar rats (n = 60) were subjected to thromboembolic occlusion (TE) of the middle cerebral artery (MCA). Thrombolysis (T) was performed with intravenous recombinant tissue-plasminogen activator (rt-PA) 1 h (early T) or 3 h (late T) after TE. Hypothermia (Hy) was applied for 4 h at 33°C started 1 h after TE. Experimental groups included control (C), early thrombolysis (ET), late thrombolysis (LT), hypothermia (Hy), early thrombolysis plus hypothermia (ET+Hy), and late thrombolysis plus hypothermia (LT+Hy). Animals were investigated by MRI and silver infarct staining (SIS) to assess the cerebral infarct size. All animals of group Hy survived, in contrast to 40% in group C (P < 0.05). ET+HY and LT+Hy showed a trend towards better survival as compared to ET and LT alone. PWI parameters were not significantly different between ET versus ET+HY and LT versus LT+Hy, but rt-PA administration led to improved cerebral perfusion in MRI. Significant differences in infarct volumes (T2/SIS) were found after 24 h in all treatment groups versus the control group (P < 0.05). The lesion volume calculated from T2 was significantly smaller in ET (16% ± 5%), ET+Hy (10 ± 4%), and LT+Hy (20% ± 9%) after 5.5 h (10.8% ± 4.8%) versus C (42% ± 15%), (P < 0.05).These data indicate that hypothermia improves survival and decreases infarct volume. However, there were no significant differences between the use of rt-PA alone or in combination with hypothermia. Further studies are needed to confirm these effects, also several days after stroke onset. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
11. Exogenous brain-derived neurotrophic factor prevents postischemic downregulation of [3H]muscimol binding to GABAA receptors in the cortical penumbra
- Author
-
Sommer, Clemens, Kollmar, Rainer, Schwab, Stefan, Kiessling, Marika, and Schäbitz, Wolf-Rüdiger
- Subjects
- *
AUTORADIOGRAPHY , *ISCHEMIA - Abstract
We have previously shown that exogenous application of brain-derived neurotrophic factor (BDNF) reduces infarct volume in the cortical ischemic penumbra after experimental focal ischemia [Stroke 31 (2000) 2212–2217]. Since BDNF is known to modulate the expression and function of various neurotransmitter receptors, we addressed the question whether BDNF may act via modification of postischemic ligand binding to excitatory NMDA and AMPA and/or inhibitory GABAA receptors, respectively. Transient focal cerebral ischemia was induced in male Wistar rats for 2 h using the suture occlusion technique. A period of 30 min after occlusion of the middle cerebral artery, BDNF (300 μg/kg per hour in vehicle; n=5) or vehicle alone (n=5) was continuously infused intravenously for 3 h. Using quantitative receptor autoradiography, postischemic ligand binding of [3H]MK-801, [3H]AMPA and [3H]muscimol was analyzed in the ischemic core, the ischemic cortical penumbra and corresponding regions of the contralateral hemisphere. Transient focal ischemia caused a significant reduction of [3H]muscimol binding to GABAA receptors within the ischemic cortical penumbra of placebo-treated rats. This was largely prevented by exogenous application of BDNF. [3H]MK-801 and [3H]AMPA binding values were also reduced in the cortical penumbra and the corresponding area of the contralateral hemisphere. Our data suggest that the neuroprotective effect of BDNF against ischemic damage in the cortical penumbra may be mediated in part by maintained activity of the inhibitory GABAergic system which likely counteracts glutamate induced excitotoxicity. [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
12. Multimodal functional imaging of prolonged neurological deficits in a patient suffering from familial hemiplegic migraine
- Author
-
Gutschalk, Alexander, Kollmar, Rainer, Mohr, Alexander, Henze, Marcus, Ille, Nicole, Schwaninger, Markus, Hartmann, Marius, Hähnel, Stefan, Haberkorn, Uwe, Rupp, André, and Meyding-Lamade, Uta
- Subjects
- *
MIGRAINE , *MAGNETOENCEPHALOGRAPHY , *POSITRON emission tomography - Abstract
The case of a patient with familial hemiplegic migraine (FHM) suffering from prolonged right sided hemiparesis and aphasia that persisted for more than 10 days is reported. The symptoms were accompanied by slowing of the magnetoencephalogram over the left hemisphere, which normalized parallel to the clinical improvement. Positron emission tomography obtained on the 6th day revealed glucose-hypometabolism (hemispheric difference ≥10%) in left hemisphere''s fronto-basal cortex, caudate nucleus, and thalamus. In contrast, magnetic resonance imaging including perfusion and diffusion weighted imaging was normal and did not show significant alterations of cortical perfusion or water mobility during the episode. We hypothesize that this finding provides evidence for a primary neuronal dysfunction causing the prolonged neurological deficits in FHM. [Copyright &y& Elsevier]
- Published
- 2002
- Full Text
- View/download PDF
13. Cardiovascular medication seems to promote recovery of autonomic dysfunction after stroke.
- Author
-
Wang, Ruihao, Köhrmann, Martin, Kollmar, Rainer, Koehn, Julia, Schwab, Stefan, Kallmünzer, Bernd, and Hilz, Max J.
- Subjects
- *
DYSAUTONOMIA , *DIASTOLIC blood pressure , *ISCHEMIC stroke , *ANTIHYPERTENSIVE agents , *BAROREFLEXES - Abstract
Background: Stroke may compromise cardiovascular–autonomic modulation (CAM). The longitudinal post-stroke CAM alterations remain unclear as previous studies excluded patients with cardiovascular medication. This study evaluated whether CAM dysfunction improves after several months in patients under typical clinical conditions, i.e., without excluding patients with cardiovascular medication. Methods: In 82 ischemic stroke patients [33 women, 64.9 ± 8.9 years, NIHSS-scores 2 (interquartile range 1–5)], we evaluated the applications of cardiovascular medication before stroke, during autonomic tests performed within 1 week, 3 and 6 months after stroke onset. We determined resting RR intervals (RRI), systolic, diastolic blood pressures (BPsys), respiration, parameters reflecting total CAM [RRI-standard deviation (RRI-SD), RRI-total powers], sympathetic [RRI-low-frequency powers (RRI-LF), BPsys-LF powers] and parasympathetic CAM [RMSSD, RRI-high-frequency powers (RRI-HF powers)], and baroreflex sensitivity. ANOVA or Friedman tests with post hoc analyses compared patient data with data of 30 healthy controls, significance was assumed for P < 0.05. Results: More patients had antihypertensive medication after than before stroke. First-week CAM testing showed lower RRIs, RMSSD, RRI-SDs, RRI-total powers, RRI-HF powers, and baroreflex sensitivity, but higher BPsys-LF powers in patients than controls. After 3 and 6 months, patients had significantly higher RRIs, RRI-SDs, RRI-total powers, RMSSDs, RRI-HF powers, and baroreflex sensitivity, but lower BPsys-LF powers than in the 1st week; RMSSDs and RRI-HF powers no longer differed between patients and controls. However, 6-month values of RRIs, RRI-SDs, and baroreflex sensitivity were again lower in patients than controls. Conclusions: Even mild strokes compromised cardiovagal modulation and baroreflex sensitivity. After 3 months, CAM had almost completely recovered. Recovery might be related to the mild stroke severity. Presumably, CAM recovery was also promoted by the increased application of cardiovascular medication. Yet, slight CAM dysfunction after 6 months suggests continuing autonomic vulnerability. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
14. Posterior circulation ischemic stroke not involving the brainstem is associated with cardiovascular autonomic dysfunction.
- Author
-
Wang, Ruihao, Köhrmann, Martin, Kollmar, Rainer, Koehn, Julia, Schwab, Stefan, Kallmünzer, Bernd, and Hilz, Max J.
- Subjects
- *
DYSAUTONOMIA , *CARDIOVASCULAR diseases , *BARORECEPTORS , *ISCHEMIC stroke , *BRAIN stem , *OCCIPITAL lobe - Abstract
Background and purpose: Ischemic stroke may induce cardiovascular autonomic dysfunction, but most previous studies have included patients with anterior circulation ischemic stroke or brainstem stroke. It remains unclear whether posterior circulation ischemic stroke (PCIS) without brainstem involvement also compromises cardiovascular autonomic modulation (CAM). Therefore, we aimed to assess CAM in PCIS patients with and without brainstem involvement. Methods: In four subgroups of 61 PCIS patients (14 occipital lobe, 16 thalamic, 12 cerebellar, and 19 brainstem strokes) and 30 healthy controls, we recorded RR intervals (RRIs), systolic (SBP) and diastolic blood pressure (DBP), and respiration at supine rest during the first week after stroke onset. We calculated parameters reflecting total CAM (RRI‐standard deviation [RRI‐SD], RRI‐total powers), predominantly sympathetic CAM (RRI‐low‐frequency [LF] powers and SBP‐LF powers] and parasympathetic CAM (root mean square of successive RRI differences [RMSSD], RRI‐high‐frequency [HF] powers), sympathetic‐parasympathetic balance (RRI‐LF/HF ratios), and baroreflex sensitivity (BRS). Values were compared among the four PCIS groups and controls using one‐way ANOVA Kruskal–Wallis tests, with post‐hoc analyses. Significance was assumed for p < 0.05. Results: In each PCIS subgroup, values for RRI, RRI‐SD, RMSSD, RRI‐HF powers, and BRS were significantly lower, while SBP‐LF powers were higher than in the controls. Only in patients with occipital lobe stroke were RRI‐LF/HF ratios significantly higher than in controls. Otherwise, autonomic variables did not differ among the four PCIS subgroups. Conclusions: During the first week after stroke onset, our PCIS patients with occipital lobe, thalamic, cerebellar, or brainstem strokes all had reduced cardiovagal modulation, compromised baroreflex, and increased peripheral sympathetic modulation. The RRI‐LF/HF ratios suggest that sympathetic predominance is slightly more prominent after occipital lobe stroke. PCIS may trigger cardiovascular autonomic dysfunction even without brainstem involvement. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
15. Inhibited glutamate release by granulocyte-colony stimulating factor after experimental stroke
- Author
-
Han, Jun-liang, Kollmar, Rainer, Tobyas, Blank, and Schwab, Stefen
- Subjects
- *
ISCHEMIA , *BLOOD vessels , *BRAIN blood-vessels , *NEUROSCIENCES - Abstract
Abstract: We investigated the ability of granulocyte-colony stimulating factor (G-CSF) on inhibiting glutamate release by microdialysis in a rat stroke model. Male Wistar rats (n =15) were treated with either intravenous saline or G-CSF (60μg/kg) 30min after temporary middle cerebral artery occlusion (MCAO). G-CSF significantly attenuated the release of glutamate in the infarcted striatum from 30 minutes to 180 minutes after tMCAO compared with control (p <0.05). Infarct volume in G-CSF treated group (135±13mm3) reduced significantly compared to control (181±10mm3) at 24 hours after tMCAO. The result of present study show that G-CSF possess an ability to inhibit excitotoxicity after ischemic stroke. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
16. In search of the silver bullet: fast and safe cooling for brain injury?
- Author
-
Kollmar, Rainer and Schwab, Stefan
- Published
- 2005
- Full Text
- View/download PDF
17. Fatal tuberculous meningitis caused by immune restoration disease.
- Author
-
Huttner, Hagen, Kollmar, Rainer, Hug, Andreas, Meisel, Fabian, Kress, Bodo, and Schwab, Stefan
- Subjects
- *
TUBERCULOUS meningitis , *NEISSERIA meningitidis , *CENTRAL nervous system diseases , *TUBERCULOSIS , *MENINGITIS - Abstract
Discusses a case of fatal tuberculous meningitis caused by immune restorate disease. Pathophysiology; Treatment options.
- Published
- 2004
- Full Text
- View/download PDF
18. Granulocyte colony stimulating factor: just another neuroprotectant?
- Author
-
Kollmar, Rainer and Schwab, Stefan
- Subjects
- *
ANIMALS , *BIOLOGICAL models , *CRITICAL care medicine , *DRUG design , *CLINICAL drug trials , *GRANULOCYTE-colony stimulating factor , *MICE , *NEUTROPHILS , *HEAD injuries , *TREATMENT effectiveness , *NEUROPROTECTIVE agents , *PHARMACODYNAMICS , *THERAPEUTICS - Published
- 2004
- Full Text
- View/download PDF
19. Rapid recovery of poststroke cardiac autonomic dysfunction: Causes to be considered.
- Author
-
Wang, Ruihao, Moeller, Sebastian, Akhundova, Aynur, Marthol, Harald, Kollmar, Rainer, Köhrmann, Martin, and Hilz, Max J.
- Subjects
- *
DYSAUTONOMIA , *STROKE , *DIASTOLIC blood pressure , *SYSTOLIC blood pressure , *ISCHEMIC stroke - Abstract
Background and purpose: Acute stroke frequently causes cardiovascular–autonomic dysfunction (CAD). Studies of CAD recovery are inconclusive, whereas poststroke arrhythmias may wane within 72 h. We evaluated whether poststroke CAD recovers within 72 h upon stroke onset in association with neurological improvement or increased use of cardiovascular medication. Methods: In 50 ischemic stroke patients (68 ± 13 years old) who—prior to hospital‐admission—had no known diseases nor took medication affecting autonomic modulation, we assessed National Institutes of Health Stroke Scale (NIHSS) scores, RR intervals (RRIs), systolic and diastolic blood pressure (BP), respiration rate, parameters reflecting total autonomic modulation (RRI SD, RRI total powers), sympathetic modulation (RRI low‐frequency powers, systolic BP low‐frequency powers), and parasympathetic modulation (square root of mean squared differences of successive RRIs [RMSSD], RRI high‐frequency powers), and baroreflex sensitivity within 24 h (Assessment 1) and 72 h after stroke onset (Assessment 2) and compared data to those of 31 healthy controls (64 ± 10 years). We correlated delta NIHSS values (Assessment 1 – Assessment 2) with delta values of autonomic parameters (Spearman rank correlation tests; significance: p < 0.05). Results: At Assessment 1, patients were not yet on vasoactive medication and had higher systolic BP, respiration rate, and heart rate, that is, lower RRIs, but lower RRI SD, RRI coefficient of variance, RRI low‐frequency powers, RRI high‐frequency powers, RRI total powers, RMSSDs, and baroreflex sensitivity. At Assessment 2, patients were on antihypertensives, had higher RRI SD, RRI coefficient of variance, RRI low‐frequency powers, RRI high‐frequency powers, RRI total powers, RMSSDs, and baroreflex sensitivity but lower systolic blood pressure and NIHSS values than at Assessment 1; values no longer differed between patients and controls except for lower RRIs and higher respiration rate in patients. Delta NIHSS scores correlated inversely with delta values of RRI SD, RRI coefficient of variance, RMSSDs, RRI low‐frequency powers, RRI high‐frequency powers, RRI total powers, and baroreflex sensitivity. Conclusions: In our patients, CAD recovery was almost complete within 72 h after stroke onset and correlated with neurological improvement. Most likely, early initiation of cardiovascular medication and probably attenuating stress supported rapid CAD recovery. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
20. Komplikationslose Thrombolysetherapie mit rt-PA über einen intraossären Zugang nach akutem ischämischem Schlaganfall.
- Author
-
Myftiu, Anisa, Hedtmann, Günter, and Kollmar, Rainer
- Published
- 2020
- Full Text
- View/download PDF
21. Therapeutic Hypothermia and the Risk of Infection: A Systematic Review and Meta-Analysis.
- Author
-
Geurts, Marjolein, Macleod, Malcolm R., Kollmar, Rainer, Kremer, Philip H. C., and van der Worp, H. Bart
- Subjects
- *
THERAPEUTIC hypothermia , *META-analysis , *RANDOMIZED controlled trials , *RISK factors of pneumonia , *RESPIRATORY infections - Abstract
Objective: Observational studies suggest that infections are a common complication of therapeutic hypothermia. We performed a systematic review and meta-analysis of randomized trials to examine the risk of infections in patients treated with hypothermia. Data Sources: PubMed, Embase, and the Cochrane Central Register of Controlled Trials were systematically searched for eligible studies up to October 1, 2012. Study Selection: We included randomized controlled clinical trials of therapeutic hypothermia induced in adults for any indication, which reported the prevalence of infection in each treatment group. Data Extraction: For each study, we collected information about the baseline characteristics of patients, cooling strategy, and infections. Data Synthesis: Twenty-three studies were identified, which included 2,820 patients, of whom 1,398 (49.6%) were randomized to hypothermia. Data from another 31 randomized trials, involving 4,004 patients, could not be included because the occurrence of infection was not reported with sufficient detail or not at all. The risk of bias in the included studies was high because information on the method of randomization and definitions of infections lacked in most cases, and assessment of infections was not blinded. In patients treated with hypothermia, the prevalence of all infections was not increased (rate ratio, 1.21 [95% CI, 0.95-1.54]), but there was an increased risk of pneumonia and sepsis (risk ratios, 1.44 [95% CI, 1.10-1.90]; 1.80 [95% CI, 1.04-3.10], respectively). Conclusion: The available evidence, subject to its limitations, strongly suggests an association between therapeutic hypothermia and the risk of pneumonia and sepsis, whereas no increase in the overall risk of infection was observed. All future randomized trials of hypothermia should report on this important complication. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
22. Therapeutic hypothermia for acute ischemic stroke: ready to start large randomized trials?
- Author
-
Van der Worp, H. Bart, Macleod, Malcolm R., and Kollmar, Rainer
- Subjects
- *
HYPOTHERMIA , *ISCHEMIA , *CEREBROVASCULAR disease , *CLINICAL trials , *BRAIN injuries - Abstract
Therapeutic hypothermia is a means of neuroprotection well established in the management of acute ischemic brain injuries such as anoxic encephalopathy after cardiac arrest and perinatal asphyxia. As such, it is the only neuroprotective strategy for which there is robust evidence for efficacy. Although there is overwhelming evidence from animal studies that cooling also improves outcome after focal cerebral ischemia, this has not been adequately tested in patients with acute ischemic stroke. There are still some uncertainties about crucial factors relating to the delivery of hypothermia, and the resolution of these would allow improvements in the design of phase III studies in these patients and improvements in the prospects for successful translation. In this study, we discuss critical issues relating first to the targets for therapy including the optimal depth and duration of cooling, second to practical issues including the methods of cooling and the management of shivering, and finally, of factors relating to the design of clinical trials. Consideration of these factors should inform the development of strategies to establish beyond doubt the place of hypothermia in the management of acute ischemic stroke. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
23. Energy expenditure in ischemic stroke patients treated with moderate hypothermia.
- Author
-
Bardutzky, Juergen, Georgiadis, Dimitrios, Kollmar, Rainer, and Schwab, Stefan
- Subjects
- *
CORONARY disease , *HYPOTHERMIA , *INTENSIVE care units , *ISCHEMIA , *CEREBROVASCULAR disease patients , *BODY temperature , *STROKE treatment , *ANALYSIS of variance , *ARTIFICIAL respiration , *BASAL metabolism , *CALORIMETRY , *CEREBRAL ischemia , *COMPARATIVE studies , *ENERGY metabolism , *INDUCED hypothermia , *LONGITUDINAL method , *RESEARCH methodology , *MEDICAL cooperation , *NONPARAMETRIC statistics , *NUTRITIONAL assessment , *PARENTERAL feeding , *RESEARCH , *SERUM albumin , *STROKE , *TIME , *EVALUATION research , *PREDICTIVE tests , *RESEARCH bias , *OXYGEN consumption , *NUTRITIONAL status , *STANDARDS ,CEREBRAL ischemia treatment - Abstract
Objective: To determine total energy expenditure (TEE) in patients with acute ischemic stroke in the territory of the middle cerebral artery (MCA), treated with moderate hypothermia (33 degrees C).Design and Setting: Prospective study in a neurological ICU.Patients: Ten consecutive patients with severe MCA infarction undergoing moderate hypothermia.Measurements and Results: Indirect calorimetry was performed continuously over the first 6 days after admission. Mean daily TEE decreased significantly from 1549 before initiation of hypothermia to 1099, 1129, and 1157 on the first, second, and third days of hypothermia, respectively and returned to baseline values after hypothermia was terminated. The ratio of TEE to predicted basal energy expenditure declined from 1.01 before induction of hypothermia to an average of 0.74 during steady state of hypothermia and increased to 1.16 after rewarming.Conclusions: We found a significant fall in TEE in sedated, curarized, and ventilated ischemic stroke patients during moderate hypothermia. Indirect calorimetry appears to be a useful tool for measuring energy expenditure in these patients, as predicted basal energy expenditure overestimates the caloric requirements during hypothermia. [ABSTRACT FROM AUTHOR]- Published
- 2004
- Full Text
- View/download PDF
24. Neck cooling induces blood pressure increase and peripheral vasoconstriction in healthy persons.
- Author
-
Koehn, Julia, Wang, Ruihao, de Rojas Leal, Carmen, Kallmünzer, Bernd, Winder, Klemens, Köhrmann, Martin, Kollmar, Rainer, Schwab, Stefan, and Hilz, Max J.
- Subjects
- *
BLOOD pressure , *VASOCONSTRICTION , *CEREBRAL circulation , *COOLING , *NECK - Abstract
Introduction: Noninvasive temperature modulation by localized neck cooling might be desirable in the prehospital phase of acute hypoxic brain injuries. While combined head and neck cooling induces significant discomfort, peripheral vasoconstriction, and blood pressure increase, localized neck cooling more selectively targets blood vessels that supply the brain, spares thermal receptors of the face and skull, and might therefore cause less discomfort cardiovascular side effects compared to head- and neck cooling. The purpose of this study is to assess the effects of noninvasive selective neck cooling on cardiovascular parameters and cerebral blood flow velocity (CBFV). Methods: Eleven healthy persons (6 women, mean age 42 ± 11 years) underwent 90 min of localized dorsal and frontal neck cooling (EMCOOLS Brain.Pad™) without sedation. Before and after cooling onset, and after every 10 min of cooling, we determined rectal, tympanic, and neck skin temperatures. Before and after cooling onset, after 60- and 90-min cooling, we monitored RR intervals (RRI), systolic, diastolic blood pressures (BPsys, BPdia), laser Doppler skin blood flow (SBF) at the index finger pulp, and CBFV at the proximal middle cerebral artery (MCA). We compared values before and during cooling by analysis of variance for repeated measurements with post hoc analysis (significance: p < 0.05). Results: Neck skin temperature dropped significantly by 9.2 ± 4.5 °C (minimum after 40 min), while tympanic temperature decreased by only 0.8 ± 0.4 °C (minimum after 50 min), and rectal temperature by only 0.2 ± 0.3 °C (minimum after 60 min of cooling). Index finger SBF decreased (by 83.4 ± 126.0 PU), BPsys and BPdia increased (by 11.2 ± 13.1 mmHg and 8.0 ± 10.1 mmHg), and heart rate slowed significantly while MCA-CBFV remained unchanged during cooling. Conclusions: While localized neck cooling prominently lowered neck skin temperature, it had little effect on tympanic temperature but significantly increased BP which may have detrimental effects in patients with acute brain injuries. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
25. Identification of adenylate kinase 5 antibodies during routine diagnostics in a tissue-based assay: Three new cases and a review of the literature.
- Author
-
Bien, Corinna I., Nehls, Ferdinand, Kollmar, Rainer, Weis, Maria, Steinke, Wolfgang, Woermann, Friedrich, Dalmau, Josep, and Bien, Christian G.
- Subjects
- *
IMMUNOGLOBULINS , *LITERATURE reviews , *TEMPORAL lobe , *EPISODIC memory , *ENCEPHALITIS - Abstract
Antibodies against adenylate kinase 5 (AK5) have been described in patients with non-paraneoplastic limbic encephalitis, mainly in men around 70 years of age. Routine testing with specific cell-based assays is not yet available. Three patients with episodic anterograde memory problems and depression had extensive limbic lesions and developed severe atrophy, mainly of the medial temporal lobes. The antibodies were identified in serum and CSF based on the typical staining pattern of AK5 antibodies on a tissue-based assay (here, unfixed mouse brain). Subsequently, they were confirmed by a research laboratory through a cell-based assay. Unlabelled Image • AK5 antibodies are found in patients with non-paraneoplastic limbic encephalitis, mainly in men around 70 years of age. • Patients have extensive limbic lesions and develop severe atrophy, mainly of the medial temporal lobes. • AK5 antibodies can be identified by their staining pattern on a tissue-based assay. Confirmation by a cell-based assay. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
26. Estimating the Quantitative Demand of NOAC Antidote Doses on Stroke Units.
- Author
-
Pfeilschifter, Waltraud, Farahmand, Dana, Niemann, Daniela, Ikenberg, Benno, Hohmann, Carina, abruscato, Mario, Thonke, Sven, Strzelczyk, adam, Hedtmann, Günther, Neumann-Haefelin, Tobias, Kollmar, Rainer, Singer, Oliver C., Ferbert, andreas, Steiner, Thorsten, Steinmetz, Helmuth, Reihs, anke, Misselwitz, Björn, and Foerch, Christian
- Subjects
- *
STROKE treatment , *ANTICOAGULANTS , *STROKE units - Abstract
Background: The first specific antidote for non-vitamin K antagonist oral anticoagulants (NOAC) has recently been approved. NOAC antidotes will allow specific treatment for 2 hitherto problematic patient groups: patients with oral anticoagulant therapy (OAT)-associated intracerebral hemorrhage (ICH) and maybe also thrombolysis candidates presenting on oral anticoagulation (OAT). We aimed to estimate the frequency of these events and hence the quantitative demand of antidote doses on a stroke unit. Methods: We extracted data of patients with acute ischemic stroke and ICH (<24 h after symptom onset) in the years 2012-2015 from a state-wide prospective stroke inpatient registry. We selected 8 stroke units and determined the mode of OAT upon admission in 2012-2013. In 2015, the mode of OAT became a mandatory item of the inpatient registry. From the number of anticoagulated patients and the NOAC share, we estimated the current and future demand for NOAC antidote doses on stroke units. Results: Eighteen percent of ICH patients within 6 h of symptom onset or an unknown symptom onset were on OAT. Given a NOAC share at admission of 40%, about 7% of all ICH patients may qualify for NOAC reversal therapy. Thirteen percent of ischemic stroke patients admitted within 4 h presented on anticoagulation. Given the availability of an appropriate antidote, a NOAC share of 50% could lead to a 6.1% increase in thrombolysis rate. Conclusions: Stroke units serving populations with a comparable demographic structure should prepare to treat up to 1% of all acute ischemic stroke patients and 7% of all acute ICH patients with NOAC antidotes. These numbers may increase with the mounting prevalence of atrial fibrillation and an increasing use of NOAC. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
27. Granulocyte colony-stimulating factor does not promote neurogenesis after experimental intracerebral haemorrhage.
- Author
-
Kallmünzer, Bernd, Tauchi, Miyuki, Schlachetzki, Johannes C., Machold, Kristin, Schmidt, Ariana, Winkler, Jürgen, Schwab, Stefan, and Kollmar, Rainer
- Subjects
- *
GRANULOCYTES , *LEUCOCYTES , *DEVELOPMENTAL neurobiology , *INTRACEREBRAL hematoma , *CEREBRAL hemorrhage , *LABORATORY rats , *BRAIN damage - Abstract
Background Hematopoietic growth factors have been suggested to induce neuroprotective and regenerative effects in various animal models of cerebral injury. However, the pathways involved remain widely unexplored. Aims This study aimed to investigate effects of local and systemic administration of granulocyte colony-stimulating factor on brain damage, functional recovery, and cerebral neurogenesis in an intracerebral haemorrhage whole blood injection model in rats. Methods Eight-week-old male Wistar rats ( n = 100) underwent induction of striatal intracerebral haemorrhage by autologous whole blood injection or sham procedure and were randomly assigned to either (a) systemic treatment with granulocyte colony-stimulating factor (60 μg/kg) for five-days; (b) single intracerebral injection of granulocyte colony-stimulating factor (60 μg/kg) into the cavity; or (c) application of vehicle for five-days. Bromodeoxyuridine-labelling and immunohistochemistry were used to analyze proliferation and survival of newly born cells in the sub-ventricular zone and the hippocampal dentate gyrus. Moreover, functional deficits and lesion volume were assessed until day 42 after intracerebral haemorrhage. Results Differences in lesion size or hemispheric atrophy between granulocyte colony-stimulating factor-treated and control groups did not reach statistical significance. Neither systemic, nor local granulocyte colony-stimulating factor administration induced neurogenesis within the dentate gyrus or the sub-ventricular zone. The survival of newborn cells in these regions was prevented by intracerebral granulocyte colony-stimulating factor application. A subtle benefit in functional recovery at day 14 after intracerebral haemorrhage induction was observed after granulocyte colony-stimulating factor treatment. Conclusion There was a lack of neuroprotective or neuroregenerative effects of granulocyte colony-stimulating factor in the present rodent model of intracerebral haemorrhage. Conflicting results from functional outcome assessment require further research. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
28. Euro HYP-1: European multicenter, randomized, phase III clinical trial of therapeutic hypothermia plus best medical treatment vs. best medical treatment alone for acute ischemic stroke.
- Author
-
Worp, H. Bart, Macleod, Malcolm R., Bath, Philip M. W., Demotes, Jacques, Durand-Zaleski, Isabelle, Gebhardt, Bernd, Gluud, Christian, Kollmar, Rainer, Krieger, Derk W., Lees, Kennedy R., Molina, Carlos, Montaner, Joan, Roine, Risto O., Petersson, Jesper, Staykov, Dimitre, Szabo, Istvan, Wardlaw, Joanna M., and Schwab, Stefan
- Subjects
- *
THERAPEUTIC hypothermia , *CLINICAL trials , *STROKE treatment , *BRAIN injuries , *CARDIAC arrest , *HEALTH outcome assessment - Abstract
Rationale Cooling reduced infarct size and improved neurological outcomes in animal studies modeling ischemic stroke, and also improved outcome in randomized clinical trials in patients with hypoxic-ischemic brain injury after cardiac arrest. Cooling awake patients with ischemic stroke has been shown feasible in phase II clinical trials. Primary aim To determine whether systemic cooling to a target body temperature between 34·0 and 35·0°C, started within six-hours of symptom onset and maintained for 24 h, improves functional outcome at three-months in patients with acute ischemic stroke. Design International, multicenter, phase III, randomized, open-label clinical trial with blinded outcome assessment in 1500 patients aged 18 years or older with acute ischemic stroke and a National Institutes of Health Stroke Scale score of 6 up to and including 18. In patients randomized to hypothermia, cooling to a target body temperature of 34-35°C will be started within six-hours after symptom onset with rapid intravenous infusion of refrigerated normal saline or a surface cooling technique and maintained for 24 h with a surface or endovascular technique. Patients randomized to hypothermia will receive pethidine and buspirone to prevent shivering and discomfort. Primary outcome Score on the modified Rankin Scale at 91 days, as analyzed with ordinal logistic regression and expressed as a common odds ratio. Discussion With 750 patients per intervention group, this trial has 90% power to detect 7% absolute improvement at the 5% significance level. The full trial protocol is available at . Identifier: NCT01833312. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
29. Different treatment settings of Granulocyte-Colony Stimulating Factor and their impact on T cell-specific immune response in experimental stroke.
- Author
-
Dietel, Barbara, Cicha, Iwona, Achenbach, Stephan, Kollmar, Rainer, Garlichs, Christoph, and Tauchi, Miyuki
- Subjects
- *
GRANULOCYTE-colony stimulating factor , *T cells , *IMMUNE response , *STROKE treatment , *FLOW cytometry , *CEREBRAL infarction - Abstract
Highlights: [•] Both single and daily application of G-CSF reduce the infarct size in ischemic rats. [•] Single application of G-CSF is superior compared to the daily mode of application. [•] Stroke-induced reduction of T lymphocytes in peripheral blood is inhibited by G-CSF. [•] Inhibition of peripheral T lymphopenia is associated with reduced cerebral T cells. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
30. Mild Prolonged Hypothermia for Large Intracerebral Hemorrhage.
- Author
-
Staykov, Dimitre, Wagner, Ingrid, Volbers, Bastian, Doerfler, Arnd, Schwab, Stefan, and Kollmar, Rainer
- Subjects
- *
HYPOTHERMIA , *HEMORRHAGE , *THERAPEUTIC hypothermia , *EDEMA , *CATHETERS , *TOMOGRAPHY , *RANDOMIZED controlled trials - Abstract
Background: Perihemorrhagic edema (PHE) develops after intracerebral hemorrhage (ICH). It can worsen the clinical situation by its additional mass effect. Therapeutic hypothermia (TH) might be an effective method to control PHE, but has not been sufficiently studied in ICH patients. Methods: We report data on n = 25 consecutive patients with large supratentorial ICH (volume > 25 ml) who were treated by mild TH of 35 °C for 8-10 days. Body temperature was controlled by endovascular cooling catheters. We followed the clinical course during hospital stay and measured volumes of ICH and PHE in regularly performed serial cranial computed tomography. Outcome was assessed after 3 and 12 months. These data were compared to a historical group of n = 25 patients with large ICH. Results: While PHE continuously increased in the historical control group up to day 10, PHE volumes in the hypothermia group remained stable. There was a significant difference from day 3 after symptom onset. Shivering (36 %) and pneumonia (96 %) were the most frequent complications during TH. Mortality rate was 8.3 % in TH versus 16.7 % in the control group after 3 months and 28 versus 44 % after 1 year. Conclusions: These data support the promising results of our first case series on TH in large ICH. TH prevents the development of PHE and its complications. Side effects of TH appeared often, but could be treated sufficiently. Therefore, TH might represent a new therapy for PHE after large ICH, but has to be further tested in randomized trials. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
31. Suppression of dendritic cell functions contributes to the anti-inflammatory action of granulocyte-colony stimulating factor in experimental stroke
- Author
-
Dietel, Barbara, Cicha, Iwona, Kallmünzer, Bernd, Tauchi, Miyuki, Yilmaz, Atilla, Daniel, Werner G., Schwab, Stefan, Garlichs, Christoph D., and Kollmar, Rainer
- Subjects
- *
DENDRITIC cells , *INFLAMMATION , *GRANULOCYTE-colony stimulating factor , *STROKE , *NATURAL immunity , *IMMUNOHISTOCHEMISTRY , *LABORATORY rats - Abstract
Abstract: Cerebral ischemia provokes an inflammatory cascade, which is assumed to secondarily worsen ischemic tissue damage. Linking adaptive and innate immunity dendritic cells (DCs) are key regulators of the immune system. The hematopoietic factor G-CSF is able to modulate DC-mediated immune processes. Although G-CSF is under investigation for the treatment of stroke, only limited information exists about its effects on stroke-induced inflammation. Therefore, we investigated the impact of G-CSF on cerebral DC migration and maturation as well as on the mediated immune response in an experimental stroke model in rats by means of transient middle cerebral artery occlusion (tMCAO). Immunohistochemistry and quantitative PCR were performed of the ischemic brain and flow cytometrical analysis of peripheral blood. G-CSF led to a reduction of the infarct size and an improved neurological outcome. Immunohistochemistry confirmed a reduced migration of DCs and mature antigen-presenting cells after G-CSF treatment. Compared to the untreated tMCAO group, G-CSF led to an inhibited DC activation and maturation. This was shown by a significantly decreased cerebral transcription of TLR2 and the DC maturation markers, CD83 and CD86, as well as by an inhibition of stroke-induced increase in immunocompetent DCs (OX62+OX6+) in peripheral blood. Cerebral expression of the proinflammatory cytokine TNF-α was reduced, indicating an attenuation of cerebral inflammation. Our data suggest an induction of DC migration and maturation under ischemic conditions and identify DCs as a potential target to modulate postischemic cerebral inflammation. Suppression of both enhanced DC migration and maturation might contribute to the neuroprotective action of G-CSF in experimental stroke. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
32. When Decompressive Craniectomy Does Not Lead to Decompression: Sinking Skin Flap Syndrome after Intracerebral Hemorrhage.
- Author
-
Staykov, Dimitre, Huttner, Hagen B., Kollmar, Rainer, Ganslandt, Oliver, Doerfler, Arnd, Schwab, Stefan, and Köhrmann, Martin
- Subjects
- *
CEREBRAL hemorrhage , *NEUROSURGERY , *ATMOSPHERIC pressure , *NEUROLOGY , *INTRACRANIAL pressure - Abstract
No abstract available Copyright © 2010 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
33. Local Head and Neck Cooling Leads to Hypothermia in Healthy Volunteers.
- Author
-
Kallmünzer, Bernd, Beck, Alexander, Schwab, Stefan, and Kollmar, Rainer
- Subjects
- *
HYPOTHERMIA , *CEREBROVASCULAR disease patients , *BODY temperature , *HEART beat , *INTRACRANIAL pressure - Abstract
Background: Prehospital cooling of acute stroke patients would be ideal when associated with minor or no side effects. Therefore, we evaluated a cooling cap for the surface of head and cervical regions in awake volunteers. Methods: 10 healthy volunteers were treated by external cooling for 190 min using a gel-based cooling device. Vital signs, rectal temperature, tympanic temperature, the extent of shivering and individual perception of frostiness and discomfort were measured. Results: All participants (median age 35 years) successfully completed the treatment and experienced only mild to moderate discomfort. No serious adverse events and no shivering were noticed. There was a significant drop in the tympanic temperature to 34.68°C (difference from baseline: 1.7°C, 95% CI: 0.61-2.7°C, p = 0.001), in the rectal temperature to 36.65°C (difference from baseline: 0.65°C, 95% CI: 0.06-1.2°C, p = 0.019) and in the heart rate (difference from baseline: 15 beats/min, 95% CI: 0.63-30 beats/min, p = 0.035). Conclusion: Treatment with the cooling device was well tolerated by all participants. The technique had measurable effects on core body temperature (rectal) and tympanic temperature (may reflect temperature at the external ear and skin rather than intracranial). It can be considered as a simple therapeutic approach to patients with suspected stroke in the prehospital setting. Copyright © 2011 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
34. International normalised ratio normalisation in patients with coumarin-related intracranial haemorrhages - the INCH trial: a randomised controlled multicentre trial to compare safety and preliminary efficacy of fresh frozen plasma and prothrombin complex - study design and protocol
- Author
-
Steiner, Thorsten, Freiberger, Anja, Griebe, Martin, Hüsing, Johannes, Ivandic, Boris, Kollmar, Rainer, Pfefferkorn, Thomas, Wartenberg, Katja E., Weimar, Christian, Hennerici, Michael, and Poli, Sven
- Subjects
- *
INTRACEREBRAL hematoma , *VITAMIN K , *HEMORRHAGE complications , *DEATH rate , *PROTHROMBIN , *HEMOSTASIS , *TOMOGRAPHY - Abstract
Intracerebral haemorrhage is the most feared complication in patients who are on treatment with vitamin K antagonists. Vitamin K antagonist related intracerebral haemorrhage occurs in about 10% of patients. Intracerebral haemorrhage has the worst prognosis of all subtypes of stroke including spontaneous intracerebral haemorrhage, and a mortality rate of up to about 65%. The higher rate of haematoma expansion due to rebleeding is thought to be responsible for the higher mortality. Current international treatment recommendations include fresh frozen plasma and prothrombin complex concentrate. It is known that these substances lower the international normalised ratio, and thus it is assumed that normalisation of coagulopathy may lead to haemostasis and reduction of rebleeding. However, the issue of whether to use fresh frozen plasma or prothrombin complex concentrate for urgent reversal of vitamin K antagonists is unresolved: safety and efficacy of these treatments have never been studied in a randomised controlled trial. Our questions are: how effective are the two substances in normalisation of the international normalized ratio? How feasible is it to apply either of these treatments in an acute situation? What is the safety profile of each of these substances? Is there a difference in haematoma growth and clinical outcome? We designed a prospective, randomised, controlled multicentre trial to compare biological efficacy and safety of fresh frozen plasma and prothrombin complex concentrate in vitamin K antagonist related intracerebral haemorrhage. The study is observer-blinded for laboratory, neuroradiological, and clinical outcomes. Patients will be included if a computed tomography scan shows an intraparenchymal or subdural haematoma within 12 h after onset of symptoms, if the patient is on treatment with vitamin K antagonists, and the international normalized ratio is ≥2. Primary endpoint is the normalisation of the international normalized ratio (≤1·2) within three-hours after the start of antagonising therapy. Main exclusion criteria are secondary intracerebral haemorrhage, other known coagulopathies, and known acute ischaemic events. We discuss the rationale of our trial on the basis of the current recommendations and specific aspects of trial design as, time window, choice of endpoints, dosing of fresh frozen plasma and prothrombin complex concentrate, monitoring and analysis of safety parameters, and rescue treatment. This will be the first prospective trial comparing fresh frozen plasma and prothrombin complex concentrate in the indication of vitamin K antagonist related intracerebral hemorrhage. Recruitment of subjects started in August 2009. Until now, 19 patients have been included. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
35. Standardized Antipyretic Treatment in Stroke: A Pilot Study.
- Author
-
Kallmünzer, Bernd, Krause, Christiane, Pauli, Elisabeth, Beck, Alexander, Breuer, Lorenz, Köhrmann, Martin, and Kollmar, Rainer
- Subjects
- *
ANTIPYRETICS , *STANDARD operating procedure , *RESEARCH methodology , *MORTALITY , *ISCHEMIA , *PATIENTS - Abstract
Background: Fever after acute cerebral injury is associated with unfavorable functional outcome and increased mortality, but there is controversy about the optimal antipyretic treatment. This study investigated an institutional standard operating procedure (SOP) for fever treatment in stroke patients including a sequence of pharmacologic and physical interventions. Methods: A 4-step antipyretic SOP was established for patients with acute cerebral ischemia or hemorrhage and a body temperature ≥37.5°C within the first 6 days after admission. Data on the course of body temperature, duration of fever and achievement of normothermia were recorded. Results were compared to a historic control group that underwent conventional treatment. Results: A total of 77 patients (mean age 70.4 ± 14.2 yeas) received 331 antipyretic interventions. Sequential administration of paracetamol (n = 219), metamizole (n = 71) and calf packing (n = 24) resulted in a significant drop in body temperature after 60 min in each instance. In 5 of 9 cases which were refractory to previous attempts, normothermia followed the infusion of ice-cooled saline. In more than 90% of cases treated per protocol, normothermia was achieved within 120 min. Compared to conventional treatment, fever burden was significantly lower within the first 4 days after admission (p < 0.001). Conclusion: This SOP may help to optimize antipyretic treatment for stroke patients. Copyright © 2011 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
36. Alpha-stat versus pH-stat guided ventilation in patients with large ischemic stroke treated by hypothermia.
- Author
-
Kollmar R, Georgiadis D, Schwab S, Kollmar, Rainer, Georgiadis, Dimitrios, and Schwab, Stefan
- Abstract
Background: Moderate hypothermia (MH) is a therapeutic approach for ischemic stroke as well as cardiac arrest. Two different technical strategies of ventilation during MH called alpha- and pH-stat dramatically influence cerebral blood flow (CBF). In turn this might influence neuronal damage and intracranial pressure (ICP). Therefore, effects of ventilation on CBF and ICP were measured in patients undergoing MH because of large ischemic stroke to address optimal ventilation management.Methods: Eight patients (n = 8) with large ischemic stroke in the territory of the middle cerebral artery (MCA) were treated by MH of 33 degrees C within 24 h after symptom onset. MH was applied at least for 72 h. Each day, patients were ventilated repetitively with either alpha-stat or pH-stat for 60 min periods. Alpha-stat was applied between the measurements. ICP, CBF, and mean arterial blood pressure (MABP) were measured. The xenon clearance method was used to assess CBF at the bedside.Results: There were no significant differences between ICP values for alpha-stat or pH-stat during days 1 and 2 after induction of hypothermia. However, ICP was higher in the pH- as compared to the alpha-stat group (P < 0.05) and exceeded a mean of 20 mmHg on day 3. pH-stat led to a significant increase of CBF in all measures (P < 0.05), while MABP was unaffected.Conclusions: pH-stat implies a better CBF to the injured brain, while it might be dangerous by elevating ICP in more subacute stages. [ABSTRACT FROM AUTHOR]- Published
- 2009
- Full Text
- View/download PDF
37. Early Administration of Low Molecular Weight Heparin after Spontaneous Intracerebral Hemorrhage.
- Author
-
Kiphuth, Ines C., Staykov, Dimitre, Köhrmann, Martin, Struffert, Tobias, Richter, Gregor, Bardutzky, Jürgen, Kollmar, Rainer, Mäurer, Mathias, Schellinger, Peter D., Hilz, Max-Josef, Doerfler, Arnd, Schwab, Stefan, and Huttner, Hagen B.
- Subjects
- *
CEREBRAL hemorrhage treatment , *HEPARIN , *THROMBOEMBOLISM risk factors , *CEREBROVASCULAR disease patients , *PULMONARY embolism , *EMBOLISM risk factors - Abstract
Background: Venous thromboembolism (VTE) is a common complication after stroke. Application of low molecular weight heparins (LMWH) has been proven to be beneficial for the prevention of VTE in ischemic stroke patients. However, there is no consensus whether and how to administer LMWH for prevention of thrombotic complications after acute spontaneous intracerebral hemorrhage (sICH), the main concern being possible hematoma growth. The objective of this study was to assess the safety of early subcutaneous LMWH in patients with sICH with respect to hemorrhage enlargement. Methods: A total of 97 patients with sICH were analyzed. LMWH (either enoxaparin-natrium or dalteparin-natrium) were initiated within 36 h after admission in all patients without clinical evidence of hemorrhage enlargement or an absence of evidence of hematoma growth on CT. Hematoma growth (significant when >33%, moderate when >20%) was assessed on follow-up CT between days 5 and 11. Results: None of the patients showed a significant hemorrhage growth. Between days 2 and 10, 2 patients experienced a moderate hematoma enlargement of 22.4 and 20.9%. None of the included patients developed a fatal lung embolism. Conclusions: Early application of subcutaneous LMWH for prevention of venous thromboembolism seems to be safe, and probably does not increase the risk of hematoma growth in patients with sICH. Copyright © 2008 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
38. A new model of thromboembolic stroke in the posterior circulation of the rat
- Author
-
Henninger, Nils, Eberius, Karl H., Sicard, Kenneth M., Kollmar, Rainer, Sommer, Clemens, Schwab, Stefan, and Schäbitz, Wolf R.
- Subjects
- *
CEREBROVASCULAR disease , *BRAIN , *BLOOD , *BRAIN diseases - Abstract
Abstract: The prognosis of vertebrobasilar occlusion is grave and therapeutic options are limited. The aim of the present study was to develop a new model of embolic hindbrain ischemia in the rat that closely resembles the clinical situation and that can be used to study pathophysiology and treatment options. After thoracotomy in 20 male Wistar rats, 15 animals received an injection of in vitro prepared autologous blood clots into the left vertebral artery. Five animals without clot injection served as controls. Neurological deficits were assessed in all animals 2h after embolism. After 2h, five animals were sacrificed to measure cerebral blood flow (CBF) by iodo-antipyridine autoradiography, and to calculate early cerebellar swelling by comparison of both hemispheres in brain slices. In these animals, autoradiography revealed ipsilesional brain swelling and significantly reduced blood flow values relative to the contralateral (unaffected) structures. Immunohistology showed the typical pattern of focal cerebral ischemia in the brain stem and/or cerebellum in 7 of 10 animals allowed to recover to 24h. Hence, successful thromboembolism was achieved in 12 of 15 animals (80%). With this novel model, the pathophysiology and potential treatments of posterior circulation stroke can be investigated. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
39. Impaired spatial learning in a novel rat model of mild cerebral concussion injury
- Author
-
Henninger, Nils, Dützmann, Stephan, Sicard, Kenneth M., Kollmar, Rainer, Bardutzky, Jürgen, and Schwab, Stefan
- Subjects
- *
BRAIN injuries , *MUSCLE contraction , *BLOOD pressure , *HEART beat - Abstract
Abstract: The aim of the present study was to develop a model of mild traumatic brain injury in the rat that mimics human concussive brain injury suitable to study pathophysiology and potential treatments. 34 male Wistar rats received a closed head trauma (TBI) and 30 animals served as controls (CON). Immediately following trauma, animals lost their muscle tone and righting reflex response, recovering from the latter within 11.4 ± 8.2 min. Corneal reflex and whisker responses returned within 4.5 ± 3.0 min and 6.1 ± 2.9 min, respectively. The impact resulted in a short transient decrease of pO2 (P < 0.001), increase in mean arterial blood pressure (P = 0.026), and a reduction of heart rate (P < 0.01). Serial MRI did not show any abnormalities across the entire cerebrum on diffusion, T1, T2, and T2*-weighted images at all investigated time points. TBI animals needed significantly longer to locate the hidden platform in a Morris water maze and spent less time in the training quadrant than controls. TBI led to a significant neuronal loss in frontal cortex (P < 0.001), as well as hippocampal CA3 (P = 0.017) and CA1 (P = 0.002) at 9 days after the trauma; however, cytoskeletal architecture was preserved as indicated by normal βAPP- and MAP-2 staining. We present a unique, noninvasive rat model of mild closed head trauma with characteristics of human concussion injury, including brief loss of consciousness, cognitive impairment, and minor brain injury. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
40. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis.
- Author
-
Schneider, Armin, Krüger, Carola, Steigleder, Tobias, Weber, Daniela, Pitzer, Claudia, Laage, Rico, Aronowski, Jaroslaw, Maurer, Martin H., Gassler, Nikolaus, Mier, Walter, Hasselblatt, Martin, Kollmar, Rainer, Schwab, Stefan, Sommer, Clemens, Bach, Alfred, Kuhn, Hans-Georg, and Schäbitz, Wolf-Rüdiger
- Subjects
- *
DEVELOPMENTAL neurobiology , *CEREBROVASCULAR disease , *NERVOUS system , *NEURODEGENERATION , *CEREBROSPINAL fluid , *BLOOD-brain barrier - Abstract
G-CSF is a potent hematopoietic factor that enhances survival and drives differentiation of myeloid lineage cells, resulting in the generation of neutrophilic granulocytes. Here, we show that G-CSF passes the intact blood-brain barrier and reduces infarct volume in 2 different rat models of acute stroke. G-CSF displays strong antiapoptotic activity in mature neurons and activates multiple cell survival pathways. Both G-CSF and its receptor are widely expressed by neurons in the CNS, and their expression is induced by ischemia, which suggests an autocrine protective signaling mechanism. Surprisingly, the G-CSF receptor was also expressed by adult neural stem cells, and G-CSF induced neuronal differentiation in vitro. G-CSF markedly improved long-term behavioral outcome after cortical ischemia, while stimulating neural progenitor response in vivo, providing a link to functional recovery. Thus, G-CSF is an endogenous ligand in the CNS that has a dual activity beneficial both in counteracting acute neuronal degeneration and contributing to long-term plasticity after cerebral ischemia. We therefore propose G-CSF as a potential new drug for stroke and neurodegenerative diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
41. Evolution of early perihemorrhagic changes—ischemia vs. edema: An MRI study in rats
- Author
-
Orakcioglu, Berk, Fiebach, Jochen B., Steiner, Thorsten, Kollmar, Rainer, Jüttler, Eric, Becker, Kristina, Schwab, Stefan, Heiland, Sabine, Meyding-Lamadé, Uta K., and Schellinger, Peter D.
- Subjects
- *
CEREBRAL ischemia , *NERVOUS system injuries , *BLOOD circulation disorders , *EDEMA - Abstract
Abstract: Objectives:: Cerebral ischemia has been proposed as a contributing mechanism to secondary neuronal injury after intracranial hemorrhage (ICH). The search for surrogate parameters that allow treatment stratification for spontaneous ICH continues. We aimed to examine perihemorrhagic ischemic changes with an animal experimental MRI study. Methods:: A high field MRI compatible setup for male Wistar rats was established using a double injection model. ICH was stereotactically placed into the right basal ganglia of 29 Wistar rats. Coronal T2-WI, T2*-WI and DWI were generated with a 2.35 T animal MRI scanner 15 min, 60 min and 210 min after ICH. Clot signal characteristics, clot volumes and normalized ADC values were analyzed in four hematoma regions (core, periphery, outer rim, healthy ipsilateral tissue) in all sequences. Results:: T2*-WI and DWI reliably demonstrated ICH in 100% with only small deviation from the applied volume (−20% to +26%) whereas T2-WI failed to conspicuously show ICH. There were no perihemorrhagic ADC decreases consistent with ischemic cytotoxic edema but a mild vasogenic edema surrounding the ICH could be observed. Conclusion:: T2*-WI and DWI are accurate for the diagnosis of hyperacute ICH. According to serial and crossectional ADC analysis, there is no hint towards the existence of a perihemorrhagic ischemic area that might be saved by early intervention. Future studies should focus on perfusion and metabolic/neurotoxic studies of this particular area and neurotoxic properties of the surrounding edema. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
42. Correction to: Neck cooling induces blood pressure increase and peripheral vasoconstriction in healthy persons.
- Author
-
Koehn, Julia, Wang, Ruihao, de Rojas Leal, Carmen, Kallmünzer, Bernd, Winder, Klemens, Köhrmann, Martin, Kollmar, Rainer, Schwab, Stefan, and Hilz, Max J.
- Subjects
- *
BLOOD pressure , *VASOCONSTRICTION , *COOLING , *NECK - Abstract
A Correction to this paper has been published: https://doi.org/10.1007/s10072-021-05355-3 [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
43. Bilateral Enhancement of the Cranial Nerves III–XII in Severe Miller-Fisher Syndrome.
- Author
-
Kiphuth, Ines Christine, Saake, Marc, Lunkenheimer, Jens, Dörfler, Arnd, Schwab, Stefan, and Kollmar, Rainer
- Subjects
- *
GUILLAIN-Barre syndrome , *CRANIAL nerves , *MEDICAL imaging systems , *CEREBROSPINAL fluid , *GADOLINIUM , *ELECTROPHYSIOLOGY , *MAGNETIC resonance imaging , *DIAGNOSIS - Abstract
The article presents the case of a 23-year-old female who was diagnosed with an acute polyradiculoneuritis. It cites that the clinical diagnosis was supported by the result of electrophysiological and cerebrospinal fluid (CSF) method. Moreover, the finding of magnetic resonance imaging (MRI) show symmetric gadolinium enhancement of the cranial nerves and cauda equine.
- Published
- 2009
- Full Text
- View/download PDF
44. Corrigendum to “Inhibited glutamate release by granulocyte-colony stimulating factor after experimental stroke” [Neurosci. Lett. 432 (2008) 167–169]
- Author
-
Han, Jun-liang, Blank, Tobias, Schwab, Stefan, and Kollmar, Rainer
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.